These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 27166654)
1. Low-fidelity alternative DNA repair carcinogenesis theory may interpret many cancer features and anticancer strategies. Jiang C; Starr S; Chen F; Wu J Future Oncol; 2016 Aug; 12(16):1897-910. PubMed ID: 27166654 [TBL] [Abstract][Full Text] [Related]
2. Low-fidelity compensatory backup alternative DNA repair pathways may unify current carcinogenesis theories. Wu J; Starr S Future Oncol; 2014 May; 10(7):1239-53. PubMed ID: 24947263 [TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribosyl)ation in carcinogenesis. Masutani M; Fujimori H Mol Aspects Med; 2013 Dec; 34(6):1202-16. PubMed ID: 23714734 [TBL] [Abstract][Full Text] [Related]
4. Role and therapeutic potential of CDK12 in human cancers. Chilà R; Guffanti F; Damia G Cancer Treat Rev; 2016 Nov; 50():83-88. PubMed ID: 27662623 [TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of DNA repair gene methylation and protein expression during chemical-induced rat lung carcinogenesis. Liu WB; Ao L; Cui ZH; Zhou ZY; Zhou YH; Yuan XY; Xiang YL; Cao J; Liu JY Biochem Biophys Res Commun; 2011 May; 408(4):595-601. PubMed ID: 21530494 [TBL] [Abstract][Full Text] [Related]
6. Patterns of mutation in cancer cells. Meuth M Cancer Surv; 1996; 28():33-46. PubMed ID: 8977027 [TBL] [Abstract][Full Text] [Related]
7. DNA repair in cancer initiation, progression, and therapy-a double-edged sword. Kiwerska K; Szyfter K J Appl Genet; 2019 Nov; 60(3-4):329-334. PubMed ID: 31468363 [TBL] [Abstract][Full Text] [Related]
8. Genetic alterations and DNA repair in human carcinogenesis. Dixon K; Kopras E Semin Cancer Biol; 2004 Dec; 14(6):441-8. PubMed ID: 15489137 [TBL] [Abstract][Full Text] [Related]
9. Cancer of the microsatellite mutator phenotype. Perucho M Biol Chem; 1996 Nov; 377(11):675-84. PubMed ID: 8960367 [TBL] [Abstract][Full Text] [Related]
10. Double strand break (DSB) repair in heterochromatin and heterochromatin proteins in DSB repair. Lemaître C; Soutoglou E DNA Repair (Amst); 2014 Jul; 19():163-8. PubMed ID: 24754998 [TBL] [Abstract][Full Text] [Related]
11. Molecular inhibitors of DNA repair: searching for the ultimate tumor killing weapon. Nikitaki Z; Michalopoulos I; Georgakilas AG Future Med Chem; 2015 Aug; 7(12):1543-58. PubMed ID: 26306465 [TBL] [Abstract][Full Text] [Related]
12. Molecular pathways: exploiting tumor-specific molecular defects in DNA repair pathways for precision cancer therapy. Dietlein F; Reinhardt HC Clin Cancer Res; 2014 Dec; 20(23):5882-7. PubMed ID: 25451105 [TBL] [Abstract][Full Text] [Related]
13. Fidelity of DNA replication by extracts of normal and malignantly transformed human cells. Boyer JC; Thomas DC; Maher VM; McCormick JJ; Kunkel TA Cancer Res; 1993 Jul; 53(14):3270-5. PubMed ID: 8391921 [TBL] [Abstract][Full Text] [Related]
14. Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches. Dietlein F; Thelen L; Reinhardt HC Trends Genet; 2014 Aug; 30(8):326-39. PubMed ID: 25017190 [TBL] [Abstract][Full Text] [Related]
15. Evolution of cancer suppression as revealed by mammalian comparative genomics. Tollis M; Schiffman JD; Boddy AM Curr Opin Genet Dev; 2017 Feb; 42():40-47. PubMed ID: 28161621 [TBL] [Abstract][Full Text] [Related]
16. Bacterial DNA repair genes and their eukaryotic homologues: 2. Role of bacterial mutator gene homologues in human disease. Overview of nucleotide pool sanitization and mismatch repair systems. Arczewska KD; Kuśmierek JT Acta Biochim Pol; 2007; 54(3):435-57. PubMed ID: 17893750 [TBL] [Abstract][Full Text] [Related]
17. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. Vineis P; Manuguerra M; Kavvoura FK; Guarrera S; Allione A; Rosa F; Di Gregorio A; Polidoro S; Saletta F; Ioannidis JP; Matullo G J Natl Cancer Inst; 2009 Jan; 101(1):24-36. PubMed ID: 19116388 [TBL] [Abstract][Full Text] [Related]
18. "Contextual" synthetic lethality and/or loss of heterozygosity: tumor hypoxia and modification of DNA repair. Chan N; Bristow RG Clin Cancer Res; 2010 Sep; 16(18):4553-60. PubMed ID: 20823145 [TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of cancer-specific synthetic lethal interactions provides insight into personalized anticancer therapy. Guo L; Dou Y; Xiang Y; Luo L; Xu X; Wang Q; Zhang Y; Liang T FEBS J; 2023 Mar; 290(6):1531-1548. PubMed ID: 36181326 [TBL] [Abstract][Full Text] [Related]
20. Mismatch repair, genetic stability and tumour avoidance. Modrich P Philos Trans R Soc Lond B Biol Sci; 1995 Jan; 347(1319):89-95. PubMed ID: 7746860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]